Daily Archives: July 25, 2022
Brief Review | Contraception in women with cardiovascular disease.
25 Jul, 2022 | 13:05h | UTCContraception in Women With Cardiovascular Disease – JAMA (free for a limited period)
Monkeypox virus infection in humans across 16 countries — April–June 2022.
25 Jul, 2022 | 13:09h | UTCCommentary: Largest monkeypox study to date highlights new symptoms – CIDRAP
Related: WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Commentary on Twitter
In this report, 528 cases of monkeypox across 16 countries are described. Rash, mucosallesions, fever, lethargy, and lymphadenopathy were common clinical findings. Few patients were hospitalized. https://t.co/SPTVK1vBRl pic.twitter.com/PNWDuAb7AG
— NEJM (@NEJM) July 21, 2022
WHO declares global public health emergency over Monkeypox virus outbreak.
25 Jul, 2022 | 13:11h | UTCWHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970–2019: a systematic analysis for the Global Burden of Disease Study 2019.
25 Jul, 2022 | 13:07h | UTCCommentary: Global Study Shows Contraception Needs Often Unmet for Young Women – HealthDay
Commentary on Twitter
NEW—160 million women worldwide have unmet #contraception needs.
Study reveals large differences in types of contraceptives used across regions and age groups: https://t.co/bIcDBxcLMf pic.twitter.com/o95QCUUFPX
— The Lancet (@TheLancet) July 21, 2022
[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.
25 Jul, 2022 | 13:01h | UTCNews Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute
Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay
Retrospective Cohort Study | Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old.
25 Jul, 2022 | 13:03h | UTCRelated:
Cohort Study | Fatty liver disease is not associated with increased mortality in the elderly.
25 Jul, 2022 | 12:59h | UTCCommentary: Fatty liver disease may not affect mortality risk in elderly patients – ACP Gastroenterology
Multidisciplinary guidelines for diagnosis and referral in cerebral visual impairment.
25 Jul, 2022 | 12:57h | UTC
M-A | TSH and FT4 reference intervals in pregnancy.
25 Jul, 2022 | 12:56h | UTC
Cohort Study | Taiwan’s nationwide Hepatitis B vaccination and antiviral therapy program reduced end-stage liver disease burden.
25 Jul, 2022 | 12:54h | UTC
Commentary on Twitter
This cohort study found the nationwide implementation of hepatitis B vaccination (1984) and antiviral treatment programs (2003) was followed by dramatic reductions in the burden of end-stage liver disease in Taiwan. https://t.co/Qnei2abi85
— JAMA Network Open (@JAMANetworkOpen) July 18, 2022
M-A | Antihistamines are better than benzodiazepines for symptomatic control in patients with acute vertigo.
25 Jul, 2022 | 12:52h | UTCEfficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo: A Systematic Review and Meta-analysis – JAMA Neurology (link to abstract – $ for full-text)
Commentary on Twitter
Study found #benzodiazepines were inferior to #antihistamines for immediate relief of acute #vertigo. Benzodiazepine use is not supported by randomized controlled data for improvement in any outcomes related to acute vertigo. https://t.co/e9NQ1hFMIK
— JAMA Neurology (@JAMANeuro) July 18, 2022
RCT | Ticagrelor is ineffective for reducing vaso-occlusive crises in pediatric sickle cell disease.
25 Jul, 2022 | 12:50h | UTC
Systematic Review | Cognitive behavioral therapy (group) for schizophrenia.
25 Jul, 2022 | 12:48h | UTCCognitive behavioural therapy (group) for schizophrenia – Cochrane Library
Summary: Group cognitive behavioural therapy for schizophrenia – Cochrane Library
RCT | Efficacy and safety of Abrocitinib vs. Dupilumab in adults with moderate-to-severe atopic dermatitis.
25 Jul, 2022 | 12:44h | UTCEfficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial – The Lancet (link to abstract – $ for full-text)
Related: Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine
Systematic Review | Taxane monotherapy regimens for treating recurrent epithelial ovarian cancer.
25 Jul, 2022 | 12:47h | UTC
RCT | Follow-up schedule for patients with sentinel node negative cutaneous melanoma.
25 Jul, 2022 | 12:43h | UTCFollow-up Schedule for Patients with Sentinel Node Negative Cutaneous Melanoma: an International Phase III Randomised Clinical Trial – Annals of Surgery (link to abstract – $ for full-text)
5-year outcomes of a RCT | Encorafenib plus Binimetinib vs. Vemurafenib or Encorafenib in patients with BRAF V600–mutant melanoma.
25 Jul, 2022 | 12:41h | UTC
RCT | Effectiveness of intensive vs. minimalist follow-up regimen on survival in patients with endometrial cancer.
25 Jul, 2022 | 12:42h | UTCEffectiveness of Intensive Versus Minimalist Follow-Up Regimen on Survival in Patients With Endometrial Cancer (TOTEM Study): A Randomized, Pragmatic, Parallel Group, Multicenter Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)